2025-01-16 14:05:55
PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT
Corporate/ 2023-07-24
PHASE II CLINICAL STUDY AT WEILL CORNELL...

SYDNEY,Feb. 28,2022--Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA),an oncology-focused drug development company,is pleased to announce...

Alphamab Oncology Announced Publication of Clinical Results of KN026 in HER2-positive Breast Cancer in Clinical Cancer Research
Corporate/ 2023-07-24
Alphamab Oncology Announced Publication ...

SUZHOU,China,Feb. 24,2022-- Alphamab Oncology (stock code: 9966.HK) announced Clinical Cancer Research,a journal of the American Association...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release